Rather than targeting one or two specific genes or proteins that contribute to cancer, the task force was charged with researching a broad-spectrum approach. “This type of approach involves combinations of multiple low-toxicity agents that can...
18-Nov-2015 9:05 AM EST Add to Favorites
Lenalidomide Plus Rituximab Produces Durable Responses in Mantle Cell Lymphoma Patients in Phase 2 Study
TAMPA, Fla. – New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma. The results from the...
12-Nov-2015 9:05 AM EST Add to Favorites
Moffitt Cancer Center Researchers Discover Link Between Genetic Mutations, Proliferation, Immune Surveillance in Lung Cancer
There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, Moffitt Cancer Center performed an extensive genetic...
11-Nov-2015 2:05 PM EST Add to Favorites
Moffitt Cancer Center’s Physical Sciences – Oncology Center Receives $10.4 Million Grant to Study the Intersection of Evolution and Cancer Therapy
TAMPA, Fla. – Moffitt Cancer Center has long recognized the need to integrate mathematicians into cancer research to better understand the complex dynamics that govern cancer growth and treatment. The Integrated Mathematical Oncology (IMO)...
6-Nov-2015 9:30 AM EST Add to Favorites
Moffitt Cancer Center Researchers Develop Novel Theoretical Approach to Reduce Antibiotic Resistance
Moffitt Cancer Center researchers have developed a novel mathematical method inspired by Darwinian evolution to use current antibiotics to eliminate or reduce the development of antibiotic-resistant bacteria.
9-Oct-2015 11:00 AM EDT Add to Favorites
Moffitt Cancer Center’s Peter Kanetsky Named Next President of the American Society of Preventive Oncology
Peter A. Kanetsky, Ph.D., M.P.H., chair and program leader of Cancer Epidemiology at the Moffitt Cancer Center, has been elected as the new president for the American Society of Preventive Oncology (ASPO).
9-Oct-2015 10:45 AM EDT Add to Favorites
Moffitt Cancer Center Researchers Make Important Steps toward Developing a Blood Test to Catch Pancreatic Cancer Early
Pancreatic cancer is the fourth most common cause of cancer-related death in the United States and has a 5-year survival rate of only 6 percent, which is the lowest rate of all types of cancer according to the American Cancer Society. This low...
28-Aug-2015 10:00 AM EDT Add to Favorites
Moffitt Cancer Center researchers recently conducted the largest U.S. based study of BRCA mutation frequency in young black women diagnosed with breast cancer at or below age 50 and discovered they have a much higher BRCA mutation frequency than...
25-Aug-2015 9:00 AM EDT Add to Favorites